Phocas Financial Corp. Pfizer Inc Transaction History

Phocas Financial Corp.

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 Apr 13, 2023	SELL	$39.39 - $51.28 $19,143 - $24,922	-486 Reduced 8.86%	5,000 $204,000
Q4 2022 Jan 10, 2023	SELL	$41.75 - $54.5 $23,964 - $31,283	-574 Reduced 9.47%	5,486 $0
Q1 2022 May 25, 2022	SELL	$45.75 - $56.69 $4,575 - $5,669	-100 Reduced 1.62%	6,060 $314,000
Q4 2021 Feb 15, 2022	BUY	$41.32 - $61.25 $21,651 - $32,095	524 Added 9.3%	6,160 $364,000
Q3 2020 Nov 13, 2020	BUY	$31.75 - $37.25 $178,943 - $209,941	5,636 New	5,636 $196,000
Q1 2020 May 15, 2020	SELL	$27.03 - $38.62 $152,341 - $217,662	-5,636 Closed	0 $0
Q1 2019 May 13, 2019	SELL	$37.5 - $41.2 $13,125 - $14,420	-350 Reduced 5.85%	5,636 $239,000
Q4 2018 Feb 15, 2019	BUY	$38.47 - $43.86 $11,541 - $13,158	300 Added 5.28%	5,986 $261,000
Q3 2018 Nov 15, 2018	SELL	$34.47 - $41.81 $9,479 - $11,497	-275 Reduced 4.61%	5,686 $251,000
Q3 2017 Nov 17, 2017	BUY	$31.0 - $34.15 $184,791 - $203,568	5,961	5,961 $0

3,260

3.61B

77.2M

122M

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $148B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

Get notified when there are updates to the investment portfolio of Phocas Financial Corp., based on Form 13F filings with the SEC.

Stay updated on Phocas Financial Corp. with notifications on news.